A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine
Clinical trial NCT00735475 · COMPLETED
Trial details
- NCT number
- NCT00735475
- Sponsor
- Seqirus
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2009-01-01
- Enrollment
- 1268
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.